DAVENPORT & Co LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 31 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
DAVENPORT & Co LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$9,0000.0%20,0000.0%0.00%
Q2 2019$9,0000.0%20,0000.0%0.00%
Q1 2019$9,000
+50.0%
20,0000.0%0.00%
Q4 2018$6,000
-60.0%
20,0000.0%0.00%
Q3 2018$15,000
+66.7%
20,0000.0%0.00%
Q2 2018$9,000
-99.9%
20,0000.0%0.00%
Q1 2018$10,798,00020,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,383,889$2,546,0002.01%
Consonance Capital Management LP 5,077,338$9,342,0001.20%
RTW INVESTMENTS, LP 843,851$1,553,0000.58%
Camber Capital Management LP 2,000,000$3,680,0000.24%
MENORA MIVTACHIM HOLDINGS LTD. 1,200,680$2,209,0000.19%
GREAT POINT PARTNERS LLC 213,215$392,0000.19%
Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) 703,443$1,294,0000.12%
FEDERATED HERMES, INC. 9,344,497$17,194,0000.05%
Spark Investment Management LLC 80,400$147,0000.02%
Baillie Gifford 6,510,158$11,979,0000.02%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders